Process of manufacturing viral vaccines in suspension avian embryonic derived stem cell lines

Details for Australian Patent Application No. 2006234304 (hide)

Owner Vivalis

Inventors Champion-Arnaud, Patrick; Leon, Arnaud; Mehtali, Majid

Agent Freehills

Pub. Number AU-B-2006234304

PCT Pub. Number WO2006/108846

Priority 0503583 11.04.05 FR; 60/728,807 21.10.05 US

Filing date 11 April 2006

Wipo publication date 19 October 2006

Acceptance publication date 13 October 2011

International Classifications

C12N 5/0735 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Embryonic stem cells

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

A61P 31/16 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C12N 7/00 (2006.01) Viruses, e.g. bacteriophages

Event Publications

15 November 2007 PCT application entered the National Phase

  PCT publication WO2006/108846 Priority application(s): WO2006/108846

13 October 2011 Application Accepted

  Published as AU-B-2006234304

9 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006234311-Seal stock laminate

2006234295-Aminoalkyl-amidomethyl-substituted 2-(4-sulphonylamino)-3-hydroxy-3,4-dih ydro-2H-chromen-6-yl derivatives and their use as potassium channel blockers